US FDA Inspection Goals Reduced After Shutdown; Review Dates Look Safe

Commissioner Scott Gottlieb tells Congress FDA won’t meet all its planned inspection goals after a month-long partial government shutdown, but he does not expect a noticeable impact on product reviews. Longer-term impacts will depend on morale: hiring and retention are focal points.

Slow-Down Sign_147945794_1200.jpg

US FDA is reducing its target for the number of medical product inspections it will conduct during fiscal 2019 as a result of the 35-day partial government shutdown at the start of the year.

“We’re lowering our inspectional and import and field sampling goals for the year,” Commissioner Scott Gottlieb told the House Appropriations/Agriculture...

More from Legislation

More from Policy & Regulation